Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
12,947,660
-
Share change
-
-167,766
-
Total reported value
-
$133,194,974
-
Price per share
-
$10.29
-
Number of holders
-
88
-
Value change
-
-$1,600,433
-
Number of buys
-
46
-
Number of sells
-
39
Institutional Holders of CONCERT PHARMACEUTICALS INC - COM (CNCE) as of Q4 2016
As of 31 Dec 2016,
CONCERT PHARMACEUTICALS INC - COM (CNCE) was held by
88 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,947,660 shares.
The largest 10 holders included
BVF INC/IL, INGALLS & SNYDER LLC, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, BlackRock Fund Advisors, Cormorant Asset Management, LLC, Numeric Investors LLC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Institutional Trust Company, N.A., and SENZAR ASSET MANAGEMENT, LLC.
This page lists
88
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.